News

Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma To Present At The Cowen And Company Annual Healthcare Conference

BOULDER, Colo., March 1, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Cowen and Company Annual Healthcare Conference in Boston.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   

Event:

Cowen and Company Annual Healthcare Conference

Presenter:

Ron Squarer, Chief Executive Officer

Date:

Wednesday, March 8, 2017

Time:

10:00 a.m. Eastern Time

Webcast:

http://wsw.com/webcast/cowen38/arry

 

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Seven registration studies are currently advancing related to six cancer drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics).

CONTACT:

Tricia Haugeto


Array BioPharma Inc.


303-386-1193


thaugeto@arraybiopharma.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-cowen-and-company-annual-healthcare-conference-300412128.html

SOURCE Array BioPharma Inc.